News & Updates

In a prospective study from China, a novel noninvasive stool DNA methylation assay showed promise for the early detection of multiple gastrointestinal (GI) cancers.

Treatment with tremelimumab plus durvalumab (STRIDE* regimen) continues to yield overall survival (OS) benefit at 4 years among patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib, according to the updated results of the HIMALAYA trial presented at ESMO WCGIC 2023.

Children and adults with atopic dermatitis (AD) are at risk of inflammatory bowel disease (IBD), with the risk varying by age, AD severity, and IBD subtype, according to a study.

Adjuvant radiotherapy following endoscopic submucosal dissection (ESD) results in better survival in patients with lymphovascular invasion (LVI) in T1bN0M0 esophageal squamous cell cancer (ESCC), a study has shown.

Endoscopic ultrasound (EUS)–guided choledocho-doudenostomy (ECDS) can be an option for primary biliary drainage in patients with unresectable malignant distal biliary obstruction (MDBO), and may be preferred when endoscopic retrograde cholangiopancreatography (ERCP) is anticipated to be difficult, according an international randomized controlled trial (RCT) led by researchers from the Chinese University of Hong Kong (CUHK).

Pantoprazole Na sesquihydrate, domperidone 40 mg/ 30 mg MR cap

At an honorary degree conferment ceremony held at the Chinese University of Hong Kong and an interview with MIMS Doctor, Professor Katalin Karikó, a pioneer of mRNA technology, suggested that recent advances in mRNA research can provide a versatile tool for combating various diseases.